Table 5. Characteristics of bone biopsy population as compared with nonbiopsy population

BiopsyNonbiopsy
a P < 0.006 baseline biopsy population versus baseline nonbiopsy population.
b P < 0.023 follow-up biopsy population versus 6-mo nonbiopsy population.
N baseline/follow-up21/1438/45
Gender (M)11 /821 /22
Age (yr)42.3 ± 13 /44.9 ± 1345 ± 12 /43.8 ± 12
Dialysis years1.8 ± 2 /1.8 ± 24.6 ± 4a /4.3 ± 4b
BMI24.3 ± 6 /23.6 ± 424.1 ± 4 /24.3 ± 5
Race (n [%])
    black6 (31.6) /3 (21.4)12 (31.6) /15 (34.9)
    Hispanic8 (42.1) /7 (50)17 (44.7) /41.9
    white4 (21.1) /3 (21.4)7 (18.4) /18.6
    other1 (5.4) /1 (7.1)2 (5.3) /2 (4.8)
ESRD (n [%])
    diabetes3 (14.3) /3 (21.4)4 (11.1) /4 (10.5)
    hypertension8 (38.1) /5 (35.7)19 (52.8) /20 (52.6)
    glomerulonephritis5 (23.8) /3 (21.4)11 (30.6) /11 (28.9)
    polycystic kidney2 (9.5) /2 (14.3)2 (5.6) /2 (5.3)
    other3 (14.3) /1 (7.1)0 /1 (2.6)